| 17.235 0.405 (2.41%) | 11-11 15:54 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.01 |
1-year : | 25.71 |
| Resists | First : | 18.85 |
Second : | 22.01 |
| Pivot price | 16.82  |
|||
| Supports | First : | 16.64 |
Second : | 15.27 |
| MAs | MA(5) : | 16.76 |
MA(20) : | 17.04 |
| MA(100) : | 19.66 |
MA(250) : | 21.87 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 34.9 |
D(3) : | 26.2 |
| RSI | RSI(14): 49 |
|||
| 52-week | High : | 27.6 | Low : | 15.27 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ KIDS ] has closed below upper band by 25.0%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.23 - 17.32 | 17.32 - 17.4 |
| Low: | 16.27 - 16.37 | 16.37 - 16.46 |
| Close: | 16.66 - 16.84 | 16.84 - 16.98 |
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Tue, 11 Nov 2025
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade - sharewise.com
Tue, 04 Nov 2025
OrthoPediatrics (Nasdaq: KIDS) to join Stifel, Jeffries, Piper; webcast, 90-day replay - Stock Titan
Thu, 30 Oct 2025
OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2025 Earnings Call Transcript - Insider Monkey
Wed, 29 Oct 2025
BTIG Reiterates OrthoPediatrics (KIDS) Buy Recommendation - Nasdaq
Tue, 28 Oct 2025
OrthoPediatrics (KIDS) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Mon, 27 Oct 2025
Earnings To Watch: OrthoPediatrics Corp (KIDS) Reports Q3 2025 R - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 25 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 32.7 (%) |
| Held by Institutions | 69.8 (%) |
| Shares Short | 1,080 (K) |
| Shares Short P.Month | 1,130 (K) |
| EPS | -1.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.18 |
| Profit Margin | -19 % |
| Operating Margin | -12.6 % |
| Return on Assets (ttm) | -4.4 % |
| Return on Equity (ttm) | -11.5 % |
| Qtrly Rev. Growth | 15.6 % |
| Gross Profit (p.s.) | 6.29 |
| Sales Per Share | 8.8 |
| EBITDA (p.s.) | -0.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -29 (M) |
| Levered Free Cash Flow | -18 (M) |
| PE Ratio | -9.57 |
| PEG Ratio | 0 |
| Price to Book value | 1.21 |
| Price to Sales | 1.95 |
| Price to Cash Flow | -14.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|